CME IS ON THE FEDERAL radar screen once again. This time the U.S. Senate is investigating pharma companies' educational grants, including funding for CME. In June, Sens. Chuck Grassley (R-Iowa) and Max Baucus (D-Montana) sent letters to pharmaceutical companies asking them to explain their practice of providing educational grants to organizations and state officials that might be in a position to influence Medicare and Medicaid drug purchasing decisions. Grassley is the chairman and Baucus ...

Register for Complete Access (Valid Email Required)

By registering on MeetingsNet now, you'll not only gain access to Printer-friendly, you'll get exclusive access to a large archive of premium content.

Already registered? here.